{
  "main_header": {
    "sid": 1003512,
    "name": "Tatva Chintan",
    "stock_name": "Tatva Chintan",
    "full_name": "Tatva Chintan Pharma Chem Ltd",
    "name_url": "stocks-analysis/tatva-chintan",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,201.10",
    "chg": 9.65,
    "chgp": "0.81%",
    "dir": 1,
    "prev_price": "1,191.45",
    "mcapval": "2,784.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543321,
    "symbol": "TATVA",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE0GK401011",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "28.72 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/tatva-chintan-1003512-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 442,
    "sid": "1003512",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/tatva-chintan-pharma-chem-1003512"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Jun-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "19-May-2026",
      "details": "Transcript of the earnings call held on 16 May 2026 post announcement of the financial results of the Company for the quarter and financial year ended 31 March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "18-May-2026",
      "details": "Submission of Annual Secretarial Compliance Report for the financial year ended 31 March 2026 (2025-2026).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Tatva Chintan Pharma Chem Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News